EcoR1 Capital
Venture Capital
Biotech-focused venture fund. Invests in drug discovery and therapeutic innovation.
San Francisco, United States · 55+ investments · 58 portfolio companies
Early Stage
Late Stage
Growth
Seed
Biotech
Drug Discovery
Life Sciences
Therapeutics
- Headquarters
- San Francisco, United States
- Founded
- 2012
- Website
- ecor1cap.com
- AUM
- $2.8B
- Portfolio Companies
- 58
- Total Investments
- 55
- Last Investment
- Jan 2026
- Geographic Focus
- G, a, b, l, o, United States
Investment Thesis
Builds long-term partnerships with bold entrepreneurs pushing therapeutic innovation forward to create new medicines for patients in biotech.
EcoR1 Capital is a Venture Capital firm based in San Francisco, United States. It has made 55 investments in Biotech and Drug Discovery, including Nuvation Bio, Neogene Therapeutics and Morphic.
Portfolio58
ST
Silverback Therapeutics
OP
ORIC PharmaceuticalsCB
Codiak BioSciences
RT
Rubius Therapeutics
Investment History
Sign up to view investment history
Create a free account — 10 credits a month to unlock deal history, amounts, and round details.